Stock Market Live 22/10 – Gilead Stock Climbs After FDA Approves Remdesivir Sam Boughedda trader Updated 22 Oct 2020 Fact Checked Disclaimer Open Demo Account YOUR CAPITAL IS AT RISK. 68% OF RETAIL CFD ACCOUNTS LOSE MONEY Sam Boughedda trader Sam is a trader and lead stock market writer at AskTraders. After starting his career in the forex market, Sam now focuses on stocks, specifically consumer staples.Â